ULS vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

ULS

38.5
AI Score
VS
ULS Wins

PACS

35.9
AI Score

Investment Advisor Scores

ULS

39score
Recommendation
SELL

PACS

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ULS PACS Winner
Revenue 4.35B 2.40B PACS
Net Income 217.88M 447.00M ULS
Net Margin 5.0% 18.6% ULS
Operating Income 329.09M 450.00M ULS
ROE 17.9% 26.2% ULS
ROA 3.7% 12.1% ULS
Total Assets 5.92B 3.69B PACS
Cash 115.28M 1.02B ULS
Debt/Equity 0.22 0.45 PACS
Current Ratio 0.80 2.09 ULS

Relative Price Performance (Last 90 Days)

ULS 1M: +14.6% · 3M: +6.4% PACS 1M: +10.8% · 3M: +8.0%

Current Technical Phase

ULS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 67

RSI (14): 67.4 · Price: $81.56

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 58

RSI (14): 57.6 · Price: $49.10

Fundamentals Snapshot

Metric ULS PACS
Market Cap — —
Forward P/E 30.9 17.5
Trailing P/E 31.2 28.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.2%
Operating Margin 0.2% 0.1%
EPS 2.60 1.73
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, ULS is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.